Investing

Investor Insight Radiopharm Theranostics represents a promising investment opportunity in the rapidly growing field of radiopharmaceuticals, leveraging its innovative technology platform and diverse clinical pipeline. Overview Radiopharm Theranostics (ASX:RAD) is an innovative biopharmaceutical company specializing…

From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as…

Cobalt prices started 2024 trading at the US$29,151.50 per metric ton level, the highest price point the battery metal achieved in 2024. By the end of the year prices had contracted by 16.68 percent to…

(TheNewswire) TORONTO, ON, January 10, 202 5 TheNewswire – Silver Crown Royalties Inc. (‘ Silver Crown ‘, ‘ SCRi ‘, the ‘ Corporation ‘, or the ‘ Company ‘) (CBOE:SCRI; OTCQX:SLCRF; FRA:QS0) wishes to provide…

The nickel market has faced challenges over the past few years due to a supply glut and weak demand. Even though the price of nickel surged in the first quarter of 2024, the higher prices…

Bold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce that it has received additional grab sample results ranging from 10 ppb Au up to 68,000 ppb Au (68 gt or 2.2…

Brunswick Exploration Inc. ( TSX-V: BRW OTCQB: BRWXF ; FRANKFURT: 1XQ ; ‘ BRW ‘ or the ‘ Company ‘) is pleased to report the last results from the Mirage summer drilling campaign. The Mirage…

Radiopharm Theranostics (RAD:AU) has announced Lantheus increases shareholding in RAD with A$8m placement Download the PDF here. This post appeared first on investingnews.com

First Helium Inc. (‘First Helium’ or the ‘Company’) (TSXV: HELI) (OTCQB: FHELF) (FRA: 2MC) today announced receipt of regulatory licensing approval to proceed with the drilling of its 7-15 high impact exploration location, along with…

(TheNewswire) To receive the annual financial statements of the company for the fiscal year ended April 30, 2024, together with the report of the auditor thereon; To fix the number of directors of the company…